{"id":8616,"date":"2023-01-06T15:49:24","date_gmt":"2023-01-06T14:49:24","guid":{"rendered":"https:\/\/semmelweis.hu\/bioinformatika\/?page_id=8616"},"modified":"2024-04-18T14:30:08","modified_gmt":"2024-04-18T12:30:08","slug":"2022-ben-megjelent-publikaciok","status":"publish","type":"page","link":"https:\/\/semmelweis.hu\/bioinformatika\/publikaciok\/2022-ben-megjelent-publikaciok\/","title":{"rendered":"2022-ben megjelent publik\u00e1ci\u00f3ink"},"content":{"rendered":"

1: M\u00fcller D, Gy\u0151rffy B.<\/strong> DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer. Biochim Biophys Acta Rev Cancer. 2022 May;1877(3):188722. doi: 10.1016\/j.bbcan.2022.188722. Epub 2022 Mar 17. PMID: 35307512.<\/p>\n

2: Bell HN, Huber AK, Singhal R, Korimerla N, Rebernick RJ, Kumar R, El-Derany MO, Sajjakulnukit P, Das NK, Kerk SA, Solanki S, James JG, Kim D, Zhang L, Chen B, Mehra R, Frankel TL, Gy\u0151rffy B<\/strong>, Fearon ER, Pasca di Magliano M, Gonzalez FJ, Banerjee R, Wahl DR, Lyssiotis CA, Green M, Shah YM. Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer. Cell Metab. 2023 Jan 3;35(1):134-149.e6. doi: 10.1016\/j.cmet.2022.11.013. Epub 2022 Dec 16. PMID: 36528023.<\/p>\n

3: Vigan\u00f2 L, Locatelli A, Ulisse A, Galbardi B, Dugo M, Tosi D, Tacchetti C, Daniele T, Gy\u0151rffy B<\/strong>, Sica L, Macchini M, Zambetti M, Zambelli S, Bianchini G, Gianni L. Modulation of the Estrogen\/erbB2 Receptors Cross-talk by CDK4\/6 Inhibition Triggers Sustained Senescence in Estrogen Receptor- and ErbB2-positive Breast Cancer. Clin Cancer Res. 2022 May 13;28(10):2167-2179. doi: 10.1158\/1078-0432.CCR-21-3185. PMID: 35254385; PMCID: PMC9595107.<\/p>\n

4: Kov\u00e1cs SA, Gy\u0151rffy B<\/strong>. Transcriptomic datasets of cancer patients treated with immune-checkpoint inhibitors: a systematic review. J Transl Med. 2022 May 31;20(1):249. doi: 10.1186\/s12967-022-03409-4. PMID: 35641998; PMCID: PMC9153191.<\/p>\n

5: Menyh\u00e1rt O, Gy\u0151rffy B<\/strong>, Szab\u00f3 A. Gyermekkori genetikai rendelleness\u00e9gek diagnosztik\u00e1ja \u00fajgener\u00e1ci\u00f3s szekven\u00e1l\u00e1ssal [Diagnosis of genetic disorders in childhood with next-generation sequencing]. Orv Hetil. 2022 Dec 18;163(51):2027-2040. Hungarian. doi: 10.1556\/650.2022.32688. PMID: 36528826.<\/p>\n

6: Munk\u00e1csy G<\/strong>, Santarpia L, Gy\u0151rffy B<\/strong>. Gene Expression Profiling in Early Breast Cancer-Patient Stratification Based on Molecular and Tumor Microenvironment Features. Biomedicines. 2022 Jan 24;10(2):248. doi: 10.3390\/biomedicines10020248. PMID: 35203458; PMCID: PMC8869155.<\/p>\n

7: Menyhart O, Weltz B, Gy\u0151rffy B.<\/strong>\u00a0 MultipleTesting.com: A tool for life science researchers for multiple hypothesis testing correction. PLoS One. 2022 Sep 9;17(9):e0274662. doi: 10.1371\/journal.pone.0274662. Erratum for: PLoS One. 2021 Jun 9;16(6):e0245824. PMID: 36084071; PMCID: PMC9462819.<\/p>\n

8: Miskey C, Botezatu L, Temiz NA, Gogol-D\u00f6ring A, Bartha \u00c1, Gy\u0151rffy B<\/strong>, Largaespada DA, Ivics Z, Sebe A. In Vitro Insertional Mutagenesis Screen Identifies Novel Genes Driving Breast Cancer Metastasis. Mol Cancer Res. 2022 Oct 4;20(10):1502-1515. doi: 10.1158\/1541-7786.MCR-21-0772. PMID: 35687718.<\/p>\n

9: \u00c1goston EI, Acs B, Herold Z, Fekete K, Kulka J, Nagy A, M\u00fchl D, Mohacsi R, Dank M, Garay T, Harsanyi L, Gy\u0151rffy B, Szasz AM.<\/strong> Deconstructing Immune Cell Infiltration in Human Colorectal Cancer: A Systematic Spatiotemporal Evaluation. Genes (Basel). 2022 Mar 25;13(4):589. doi: 10.3390\/genes13040589. PMID: 35456394; PMCID: PMC9024576.<\/p>\n

10: L\u00f3pez-Cade I, Garc\u00eda-Barber\u00e1n V, Caba\u00f1as Morafraile E, D\u00edaz-Tejeiro C, Saiz- Ladera C, Sanvicente A, P\u00e9rez Segura P, Pandiella A, Gy\u0151rffy B<\/strong>, Oca\u00f1a A. Genomic mapping of copy number variations influencing immune response in breast cancer.Front Oncol. 2022 Sep 1;12:975437. doi: 10.3389\/fonc.2022.975437. PMID: 36119512; PMCID: PMC9476651.<\/p>\n

11: P\u00e1link\u00e1s HL, Pongor L, Balajti M, Nagy \u00c1<\/strong>, Nagy K, B\u00e9k\u00e9si A, Bianchini G, V\u00e9rtessy BG, Gy\u0151rffy B.<\/strong> Primary Founder Mutations in the <i>PRKDC<\/i> Gene Increase Tumor Mutation Load in Colorectal Cancer. Int J Mol Sci. 2022 Jan 6;23(2):633. doi: 10.3390\/ijms23020633. PMID: 35054819; PMCID: PMC8775830.<\/p>\n

12: Dmello C, Sonabend A, Arrieta VA, Zhang DY, Kanojia D, Chen L, Gould A, Zhang J, Kang SJ, Winter J, Horbinski C, Amidei C, Gy\u0151rffy B<\/strong>, Cordero A, Chang CL, Castro B, Hsu P, Ahmed AU, Lesniak MS, Stupp R, Sonabend AM. Translocon- associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma. Clin Cancer Res. 2022 Jul 15;28(14):3156-3169. doi: 10.1158\/1078-0432.CCR-21-2563. PMID: 35552677.<\/p>\n

13: Olah C, Reis H, Hoffmann MJ, Mairinger F, Ting S, Hadaschik B, Krafft U, Gr\u00fcnwald V, Nyirady P, Varadi M, Gy\u0151rffy B<\/strong>, Kiss A, Szekely E, Sj\u00f6dahl G, Szarvas T. Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer. Cancer Med. 2022 Oct 7. doi: 10.1002\/cam4.5324. Epub ahead of print. PMID: 36204983.<\/p>\n

14: Alcaraz-Sanabria A, Caba\u00f1as Morafraile E, Fern\u00e1ndez-Hinojal G, Velasco G, P\u00e9rez-Segura P, Pandiella A, Gy\u0151rffy B<\/strong>, Oca\u00f1a A. Transcriptomic Mapping of Non- Small Cell Lung Cancer <i>K-RAS<\/i> p.G12C Mutated Tumors: Identification of Surfaceome Targets and Immunologic Correlates. Front Immunol. 2022 Feb 1;12:786069. doi: 10.3389\/fimmu.2021.786069. PMID: 35178045; PMCID: PMC8843839.<\/p>\n

15: Pai P, Wang G, Teo WW, Raez-Rodriguez D, Gabrielson KL, Gy\u0151rffy B<\/strong>, Downs BM, Aggarwal A, Sukumar S. HOXA5-Mediated Stabilization of I\u03baB\u03b1 Inhibits the NF-\u03baB Pathway and Suppresses Malignant Transformation of Breast Epithelial Cells. Cancer Res. 2022 Oct 17;82(20):3802 3814. doi: 10.1158\/0008-5472.CAN-21-4277. PMID: 36166646; PMCID: PMC9588663.<\/p>\n

16: Palassin P, Lapierre M, Bonnet S, Pillaire MJ, Gy\u0151rffy B<\/strong>, Teyssier C, Jalaguier S, Hoffmann JS, Cavaill\u00e8s V, Castet-Nicolas A. RIP140 regulates <i>POLK<\/i> gene expression and the response to alkylating drugs in colon cancer cells. Cancer Drug Resist. 2022 May 7;5(2):401-414. doi: 10.20517\/cdr.2021.133. PMID: 35800380; PMCID: PMC9255241.<\/p>\n

17: Harrod A, Lai CF, Goldsbrough I, Simmons GM, Oppermans N, Santos DB, Gy\u0151rffy B<\/strong>, Allsopp RC, Toghill BJ, Balachandran K, Lawson M, Morrow CJ, Surakala M, Carnevalli LS, Zhang P, Guttery DS, Shaw JA, Coombes RC, Buluwela L, Ali S. Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer. Oncogene. 2022 Oct;41(44):4905-4915. doi: 10.1038\/s41388-022-02483-8. Epub 2022 Oct 5. PMID: 36198774; PMCID: PMC7613769.<\/p>\n

18: Munk\u00e1csy G<\/strong>, Herman P, Gy\u0151rffy B.<\/strong> Comparison of scientometric achievements at PhD and scientific output ten years later for 4,790 academic researchers. PLoS One. 2022 Jul 27;17(7):e0271218. doi: 10.1371\/journal.pone.0271218. PMID: 35895676; PMCID: PMC9328526.<\/p>\n

19: Heged\u00fcs L, Livingstone E, B\u00e1nkfalvi \u00c1, Viehof J, Enyedi \u00c1, Bilecz \u00c1, Gy\u0151rffy <\/strong>B<\/strong>, Baranyi M, T\u0151k\u00e9s AM, Gil J, Marko-Varga G, Griewank KG, Zimmer L, V\u00e1raljai R, Sucker A, Zaremba A, Schadendorf D, Aigner C, Heged\u00fcs B. The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition. Int J Mol Sci. 2022 Mar 19;23(6):3324. doi: 10.3390\/ijms23063324. PMID: 35328746; PMCID: PMC8949876.<\/p>\n

20: Jacquier V, Gitenay D, Fritsch S, Bonnet S, Gy\u0151rffy B<\/strong>, Jalaguier S, Linares LK, Cavaill\u00e8s V, Teyssier C. RIP140 inhibits glycolysis-dependent proliferation of breast cancer cells by regulating GLUT3 expression through transcriptional crosstalk between hypoxia induced factor and p53. Cell Mol Life Sci. 2022 May 3;79(5):270. doi: 10.1007\/s00018-022-04277-3. PMID: 35501580; PMCID: PMC9061696.<\/p>\n

21: Kothalawala WJ, Gy\u0151rffy B.<\/strong> Transcriptomic and cellular content analysis of colorectal cancer by combining multiple independent cohorts. Clin Transl Gastroenterol. 2022 Jul 20. doi: 10.14309\/ctg.0000000000000517. Epub ahead of print. PMID: 35858620.<\/p>\n

22: Regan JL, Schumacher D, Staudte S, Steffen A, Lesche R, Toedling J, Jourdan T, Haybaeck J, Golob-Schwarzl N, Mumberg D, Henderson D, Gy\u0151rffy B<\/strong>, Regenbrecht CRA, Keilholz U, Sch\u00e4fer R, Lange M. Identification of a neural development gene expression signature in colon cancer stem cells reveals a role for <i>EGR2<\/i> in tumorigenesis. iScience. 2022 May 31;25(7):104498. doi: 10.1016\/j.isci.2022.104498. PMID: 35720265; PMCID: PMC9204726.<\/p>\n

23: Lad\u00e1nyi A, R\u00e1s\u00f3 E, Barbai T, V\u00edzkeleti L, Pusk\u00e1s LG, Kov\u00e1cs SA<\/strong>, Gy\u0151rffy B<\/strong>, T\u00edm\u00e1r J. Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy. Int J Mol Sci. 2022 Feb 28;23(5):2704. doi: 10.3390\/ijms23052704. PMID: 35269844; PMCID: PMC8911010.<\/p>\n

24: Tibor Fekete J, Gy\u0151rffy B.<\/strong> A unified platform enabling biomarker ranking and validation for 1562 drugs using transcriptomic data of 1250 cancer cell lines. Comput Struct Biotechnol J. 2022 Jun 6;20:2885-2894. doi: 10.1016\/j.csbj.2022.06.007. PMID: 35765648; PMCID: PMC9198269.<\/p>\n

25: Ding X, Sharko AC, McDermott MSJ, Schools GP, Chumanevich A, Ji H, Li J, Zhang L, Mack ZT, Sikirzhytski V, Shtutman M, Ivers L, O’Donovan N, Crown J, Gy\u0151rffy B<\/strong>, Chen M, Roninson IB, Broude EV. Inhibition of CDK8\/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo. Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2201073119. doi: 10.1073\/pnas.2201073119. Epub 2022 Aug 1. PMID: 35914167; PMCID: PMC9371674.<\/p>\n

26: Olah C, Hahnen C, Nagy N, Musial J, Varadi M, Nyiro G, Gyorffy B<\/strong>, Hadaschik B, Rawitzer J, Ting S, Sj\u00f6dahl G, Hoffmann MJ, Reis H, Szarvas T. A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer-Stromal gene expressions show higher prognostic values than intrinsic tumor genes. Int J Cancer. 2022 Mar 1;150(5):856-867. doi: 10.1002\/ijc.33809. Epub 2021 Oct 2. PMID: 34536301.<\/p>\n

27: Riecks J, Parnigoni A, Gy\u0151rffy B,<\/strong> Kiesel L, Passi A, Vigetti D, G\u00f6tte M. The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer. J Cancer Res Clin Oncol. 2022 Dec;148(12):3399-3419. doi: 10.1007\/s00432-022-04127-6. Epub 2022 Jun 29. PMID: 35767191; PMCID: PMC9587083.<\/p>\n

28: Mazzeschi M, Sgarzi M, Romaniello D, Gelfo V, Cavallo C, Ambrosi F, Morselli A, Miano C, Laprovitera N, Girone C, Ferracin M, Santi S, Rihawi K, Ardizzoni A, Fiorentino M, D’Uva G, Gy\u0151rffy B<\/strong>, Palmer R, Lauriola M. The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer. J Exp Clin Cancer Res. 2022 Mar 29;41(1):113. doi: 10.1186\/s13046-022-02309-1. PMID: 35351152; PMCID: PMC8962179.<\/p>\n

29: Kahl I, Mense J, Finke C, Boller AL, Lorber C, Gy\u0151rffy B<\/strong>, Greve B, G\u00f6tte M, Espinoza-S\u00e1nchez NA. The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients. J Cell Biochem. 2022 Mar;123(3):581-600. doi: 10.1002\/jcb.30205. Epub 2022 Jan 10. PMID: 35014077.<\/p>\n

30: Jobb\u00e1gy A, Kiss N, Meznerics FA, Farkas K, Pl\u00e1z\u00e1r D, Bozs\u00e1nyi S, F\u00e9s\u0171s L, Bartha \u00c1<\/strong>, Szab\u00f3 E, L\u0151rincz K, S\u00e1rdy M, Wikonk\u00e1l NM, Szold\u00e1n P, B\u00e1nv\u00f6lgyi A. Emergency Use and Efficacy of an Asynchronous Teledermatology System as a Novel Tool for Early Diagnosis of Skin Cancer during the First Wave of COVID-19 Pandemic. Int J Environ Res Public Health. 2022 Feb 25;19(5):2699. doi:10.3390\/ijerph19052699. PMID: 35270391; PMCID: PMC8910370.<\/p>\n

31: Mahdi M, Herm\u00e1n L, R\u00e9thelyi JM, B\u00e1lint BL<\/strong>. Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID 19. Int J Mol Sci. 2022 Mar 30;23(7):3812. doi: 10.3390\/ijms23073812. PMID: 35409171; PMCID: PMC8998734.<\/p>\n

32: Laczik M, Erd\u0151s E, Ozgyin L, Hevessy Z, Cs\u0151sz \u00c9, Kall\u00f3 G, Nagy T, Barta E, P\u00f3liska S, Szatm\u00e1ri I, B\u00e1lint BL.<\/strong> Extensive proteome and functional genomic profiling of variability between genetically identical human B-lymphoblastoid cells. Sci Data. 2022 Dec 10;9(1):763. doi: 10.1038\/s41597-022-01871-9. PMID: 36496436; PMCID: PMC9741606.<\/p>\n

33: Szeitz B, Megyesfalvi Z, Woldmar N, Valk\u00f3 Z, Schwendenwein A, B\u00e1r\u00e1ny N, Paku S, L\u00e1szl\u00f3 V, Kiss H, Bugyik E, Lang C, Sz\u00e1sz AM<\/strong>, Pizzatti L, Bogos K, Hoda MA, Hoetzenecker K, Marko-Varga G, Horvatovich P, D\u00f6me B, Schelch K, Rezeli M. In- depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer. Clin Transl Med. 2022 Sep;12(9):e1060. doi: 10.1002\/ctm2.1060. PMID: 36149789; PMCID: PMC9506422.<\/p>\n","protected":false},"excerpt":{"rendered":"

1: M\u00fcller D, Gy\u0151rffy B. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer. Biochim Biophys Acta Rev Cancer. 2022 May;1877(3):188722. doi: 10.1016\/j.bbcan.2022.188722. Epub 2022 Mar 17. PMID: 35307512. 2: Bell HN, Huber AK, Singhal R, Korimerla N, Rebernick RJ, Kumar R, El-Derany MO, Sajjakulnukit P, Das NK, Kerk SA, Solanki S, James JG, …<\/p>\n","protected":false},"author":102018,"featured_media":0,"parent":8610,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-8616","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/pages\/8616","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/users\/102018"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/comments?post=8616"}],"version-history":[{"count":10,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/pages\/8616\/revisions"}],"predecessor-version":[{"id":10213,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/pages\/8616\/revisions\/10213"}],"up":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/pages\/8610"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/media?parent=8616"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/categories?post=8616"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/tags?post=8616"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}